Seyda Bilgin

Seyda Bilgin

Auto-generated profile, based on publicly available information

Seyda Bilgin

Division of Geriatric Medicine, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in Gerontology
Verified
Journal Article
Closed access
SBSeyda Bilgin
Seyda Bilgin
VSVeysel Suzan
Veysel Suzan
BKBahar Bektan Kanat
Bahar Bektan Kanat
GAGulru Ulugerger Avci
Gulru Ulugerger Avci
SASuna Avci
Suna Avci
DEDeniz Suna Erdincler
Deniz Suna Erdincler
Introduction: The objective of this study is to assess the correlation between serum levels of DAO (Diamine oxidase), LPS (Lipopolysaccharide), I-FABP (Intestinal Fatty Acid Binding Protein), and Zonulin with primary sarcopenia in elderly patients, and to compare the diagnostic performance of these biomarkers with the SARC-F score. Methods: The study included 88 patients aged 65 and above. Comorbidities and geriatric syndromes were assessed, and those with secondary sarcopenia were excluded. The EWGSOP2 criteria were applied for diagnosing sarcopenia, while the SARC-F questionnaire was utilized to identify individuals at risk of sarcopenia. Serum levels of DAO, Zonulin, LPS, and I-FABP were measured using ELISA. Results: No significant differences were observed between the two groups regarding age and gender. SARC-F, serum DAO, and Zonulin concentrations were notably higher in the sarcopenia group than in the non-sarcopenia group (p<0.001). Statistically significant parameters were analyzed using stepwise multiple regression. In stepwise multivariate logistic regression analysis, both DAO and Zonulin scores were found to be associated with sarcopenia [Odds ratio (OR) 1.041, (95%) confidence interval (CI) 1.020-1.063, p<0.001; OR 1.108, (95%) CI 1.018-1.206, p=0.018, subsequently]. ROC curve analysis revealed that the area under the curve (AUC) for DAO, Zonulin, and SARC-F was 0.807 (p<0.001), 0.723 (p<0.001), and 0.943 (p<0.001), subsequently. The Spearman correlation test revealed a significant, low-correlation between serum Zonulin and the SARC-F score (r = 0.3583, p=0.0006), and a moderate-correlation between serum DAO and the SARC-F score (r = 0.4384, p<0.0001). Conclusion: This study is the first to show a connection between primary sarcopenia and intestinal barrier dysfunction. While the findings support the use of the SARC-F questionnaire in routine practice, serum levels of DAO and Zonulin could serve as an alternative when the SARC-F questionnaire is not applicable.

23 June 2024 in Internal and Emergency Medicine
Verified
Journal Article
Open access
PDF file
SBSeyda Bilgin
Seyda Bilgin
VSVeysel Suzan
Veysel Suzan
SASuna Avci
Suna Avci
HYHakan Yavuzer
Hakan Yavuzer
IBIbrahim Murat Bolayirli
Ibrahim Murat Bolayirli
DEDeniz Suna Erdincler
Deniz Suna Erdincler
The aim of this study is to evaluate the relationship between serum TLR (Toll Like Receptor) 4, 9 and Resolvin E1 levels and primary sarcopenia in geriatric patients and to compare the diagnostic accuracy of these biomarkers with the SARC-F score. A total of 88 patients aged 65 years and older were evaluated in the study. Comorbidities and geriatric syndromes were identified and patients with secondary sarcopenia were excluded. EWGSOP2 criteria were used as diagnostic criteria for sarcopenia and SARC-F questionnaire was used to find individuals at risk for sarcopenia. Serum TLR 4, 9 and Resolvin E1 levels were analyzed by ELISA. There were no significant differences between the two groups in terms of age and gender (p = 0.654 and p = 1.000, respectively). SARC-F, serum TLR 9 and Resolvin E1 were significantly higher in the sarcopenia group compared to the non-sarcopenia group (p < 0.001, p < 0.001 and p = 0.040, respectively). Statistically significant parameters were evaluated by multiple regression analysis. TLR 9 and SARC-F score were both found to be associated with sarcopenia in multivariate logistic regression analysis [Odds ratio (OR) 3145, (95%) confidence interval (CI) 5.9–1,652,888.3, p = 0.012; OR 4.788, (95%) CI 2.148–10.672, p < 0.001, respectively]. ROC curve analysis showed that the area under the ROC curve (AUC) for TLR 9 and SARC-F was 0.896 (p < 0.001) and 0.943 (p < 0.001), respectively. Although this study supports the use of the SARC-F questionnaire in daily practice, serum TLR 9 levels may be an alternative to SARC-F in cases where SARC-F is not feasible.

27 August 2025 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
ASAysegul Akkan Suzan
Aysegul Akkan Suzan
SBSeyda Bilgin
Seyda Bilgin
PDPelin Degirmenci
Pelin Degirmenci
NANurten Uzun Adatepe
Nurten Uzun Adatepe
ADAlper Doventas
Alper Doventas
AGAyşegül Gündüz
Ayşegül Gündüz

27 June 2025 in Harran Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
ASAysegul Akkan Suzan
Aysegul Akkan Suzan
SBSeyda Bilgin
Seyda Bilgin
VSVeysel Suzan
Veysel Suzan
Background: It was aimed to investigate the relationship between sleep duration and chronic diseases and geriatric syndromes in geriatric patients. Materials and Methods: Our cross-sectional study included 174 patients admitted to the geriatric outpatient clinic for the first time between January 2024 and June 2024. Patients under 65 years of age, with active infection, terminal illness, diagnosis of malignancy, and history of trauma and infection in the last month were excluded from the study. In our study, in accordance with the recommendations of the ‘National Sleep Foundation’ and the ‘American Academy of Sleep Medi-cine (AASM)’, we considered sleep duration over 8 hours/day as long sleep in geriatric patients. Results: In our study, 107 geriatric patients with no long sleep duration (≤8 hours) and 67 geriatric patients with long sleep duration (˃8 hours) were included. There was no significant difference between the two groups in terms of age and gender (p=0.174, p=0.739). There was no significant difference between the two groups in terms of chronic diseases, number of chronic diseases and number of medications. Sarcopenia (%49 vs %33, p=0.046) and malnutrition (%35 vs %21, p=0.041) were found to be significantly higher in patients with longer sleep duration. There was no statistically significant difference between the two groups in terms of frailty, depression, cogni-tive status, basic and instrumental activities of daily living (p=0.208, p=0.062, p=0.097, p=0.110, p=0.117). Conclusions: Sarcopenia and malnutrition were observed at a higher rate in patients with long sleep duration. Based on this, sarcopenia and malnutrition screening should be emphasised in geriatric patients with long sleep duration.

27 November 2023 in Ulusal Romatoloji Dergisi
Verified
Journal Article
Closed access
SBSeyda Bilgin
Seyda Bilgin
SUSerdal Uğurlu
Serdal Uğurlu

17 July 2026 in Medicine
Verified
Journal Article
Open access
ASAysegul Akkan Suzan
Aysegul Akkan Suzan
SBSeyda Bilgin
Seyda Bilgin
VSVeysel Suzan
Veysel Suzan
This study aimed to investigate the frequency of primary sarcopenia in individuals with and without restless legs syndrome (RLS). In this cross-sectional study, 114 patients who presented to our outpatient clinic for the first time and were diagnosed with RLS and 147 patients without RLS were consecutively included. Patients with malignancy, uncontrolled diabetes mellitus, or diseases that may cause secondary sarcopenia or neuropathy were excluded from the study. The European Working Group on Sarcopenia in Older People 2 criteria for the diagnosis of sarcopenia and the International RLS Study Group criteria for the diagnosis of RLS were applied. The association between RLS and sarcopenia was analyzed using a logistic regression analysis. There were no significant differences in terms of chronic diseases. While there was no significant difference between the groups with and without RLS (70.11 ± 9.56 vs 71.76 ± 9.61) in terms of age ( P = .170), females were significantly higher in the RLS group ( P = .001). The rate of sarcopenia was significantly higher in patients with RLS (54% vs 37%, P = .005). In the multivariate logistic regression analysis of sarcopenia and sex (female), it was determined that both were associated with RLS [odds ratio 1.941 (95%) confidence interval 1.107–3.402, P = .021; odds ratio 2.733, (95%) confidence interval 1.442–5.177, P = .002], respectively). Primary sarcopenia is more common in patients with RLS than in those without RLS. Screening for sarcopenia should be considered in patients with restless leg syndrome.